Evidence map›Paper›PMID 32921703›Full record

ArticleActa bio-medica : Atenei Parmensis2020

The successful management of Thirty-six hepatopancreatobiliary surgeries under the intensive protective arrangements during the COVID-19 pandemic.

Davood Tasa, Pegah Eslami, Habibollah Dashti, Mohsen Nassiri Toosi, Seyed Yahya Zarghami, Seyed Yahya Zarghami, Ali Jafarian

Abstract read
In one paragraph

Article in Acta bio-medica : Atenei Parmensis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Davood TasaLiver transplantation research center, imam Khomeini hospital complex, Tehran University of Medical sciences, Tehran, Iran.. davodtasa@gmail.com.
Pegah EslamiGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. pegahslm@gmail.com.
Habibollah DashtiLiver transplantation research center, imam Khomeini hospital complex, Tehran University of Medical sciences, Tehran, Iran.. habibdasht@gmail.com.
Mohsen Nassiri ToosiGastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. . ltrc.tehran@gmail.com.
Seyed Yahya ZarghamiLiver transplantation research center, imam Khomeini hospital complex, Tehran University of Medical sciences, Tehran, Iran.. syzarghami@gmail.com.
Seyed Yahya ZarghamiLiver transplantation research center, imam Khomeini hospital complex, Tehran University of Medical sciences, Tehran, Iran.. syzarghami@gmail.com.
Ali JafarianLiver transplantation research center, imam Khomeini hospital complex, Tehran University of Medical sciences, Tehran, Iran.. jafarian@tums.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ackground: During the pandemic of COVID-19, the overwhelm of infected patients created an exponential surge for ICU and ward beds. As a result, a major proportion of elective surgeries was postponed. However, various emergency and urgent procedures were allowed. Due to the mortality complications of hepatopancreatobiliary issues, we decided to afford urgent procedures under intensive protective arrangements. Method and results: In our ward (liver transplant), 4 ICU beds and 16 ward beds were allocated to non-COVID-19 patients. A total of 36 hepatopancreatobiliary procedures were managed for one month. All the surgeries were afforded under personal protective equipment and other intensive protective arrangements for personnel and patients. During 6 weeks following the surgery, all patients were followed up through telemedicine and no new case of COVID-19 was detected. Conclusion: In general, it appears that intensive protections could significantly reduce the number of COVID-19 incidence among patients with co-morbidities who undergo invasive procedures.

Indexed as

BetacoronavirusBiliary Tract DiseasesCoronavirus InfectionsCOVID-19Digestive System Surgical ProceduresDisease Transmission, InfectiousEmergency Service, HospitalFemaleHumansLiver DiseasesMaleMiddle AgedPancreatic DiseasesPandemicsPersonal Protective EquipmentPneumonia, Viral

Identifiers

PMID32921703
PMCPMC7717014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.